MALCOLM I. HOENLEIN
Conference of Presidents of Major American Jewish Organizations,
Executive Vice Chairman
In June 1986, Malcolm Hoenlein was elected Executive Vice Chairman of the Conference of Presidents of Major American Jewish Organizations, the coordinating body on international Jewish concerns for 50 national Jewish organizations. Previously, he served as the founding Executive Director of the Jewish Community Relations Council of Greater New York, the central coordinating agency for Jewish organizations in the metropolitan New York area. Prior to that, he was the founding Executive Director of the Greater New York Conference on Soviet Jewry.
Mr. Hoenlein has traveled throughout the world meeting with world leaders and Jewish communities. He has written and lectured across the US and abroad on international relations, Israel and Middle East affairs, Soviet and World Jewry, terrorism, the American Jewish community, and intergroup relations.
Mr. Hoenlein serves as an advisor to many public officials and is frequently consulted on public policy issues. He appears regularly in the media. Mr. Hoenlein played a key role in organizing the massive National Solidarity Rally for Israel in Washington, DC in 2002. The Forward listed him as the most influential Jewish leader.
The Mayor of Jerusalem announced in 2007 that the City Council had designated Mr. Hoenlein recipient of the prestigious “Neeman Yerushalayim” (Trustee of Jerusalem) award. Mr. Hoenlein was appointed by three Presidents as a member of U.S. delegations to the Organization for Security and Conference in Europe, most recently in June 2007. He also served on the New York State Ethical Standards Board.
Mr. Hoenlein is associated with and serves on the boards of many communal, educational and civic organizations including the Council on Foreign Relations, and America-Israel Chamber of Commerce. He is Chairman of America’s Voices in Israel and Co-Chair of Security Community Network. He serves on the Board of Directors or Advisory Board of several companies, including Bank Leumi USA, and Keryx Biopharmaceuticals, Inc.